Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of Moderate Buy by Analysts

Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the nine ratings firms that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12-month price […]

Related Keywords

United States ,Canada ,Pacira Biosciences ,Daryl Gaugler ,Piper Sandler ,Pacira Biosciences Inc ,R Capital Management Inc ,Us Capital Wealth Advisors ,Nasdaq ,Group Wealth Management ,Securities Exchange Commission ,Financial Freedom ,Royal Bank ,Get Free Report ,Exchange Commission ,Wealth Management ,Forest Capital Management ,Wealth Advisors ,Get Free ,Pacira Biosciences Daily ,Nasdaq Pcrx ,Pcrx ,Medical ,69512710 ,Ratings ,Consensus ,